(B21.7) Hiv disease resulting in multiple malignant neoplasms

More details coming soon

18 133 in individuals diagnosis hiv disease resulting in multiple malignant neoplasms confirmed

16 857 deaths with diagnosis hiv disease resulting in multiple malignant neoplasms

93% mortality rate associated with the disease hiv disease resulting in multiple malignant neoplasms

Etiology Pathogenesis Clinical Pattern Diagnostics Treatment Prevention

Diagnosis hiv disease resulting in multiple malignant neoplasms is diagnosed Men are 48.72% more likely than Women

13 484

Men receive the diagnosis hiv disease resulting in multiple malignant neoplasms

11 316 (83.9 %)

Died from this diagnosis.

100

4 649

Women receive the diagnosis hiv disease resulting in multiple malignant neoplasms

5 541 (119.2 %)

Died from this diagnosis.

Risk Group for the Disease hiv disease resulting in multiple malignant neoplasms - Men aged 40-44 and Women aged 30-34

In Men diagnosis is most often set at age 0-1, 25-69

Less common in men the disease occurs at Age 0-24, 70-95+Less common in women the disease occurs at Age 0-19, 25-29, 45-54, 60-74, 80-95+

In Women diagnosis is most often set at age 20-24, 30-44, 55-59, 75-79

Disease Features hiv disease resulting in multiple malignant neoplasms

Absence or low individual and public risk

Hiv disease resulting in multiple malignant neoplasms - what does this mean

Hiv disease resulting in multiple malignant neoplasms is caused by a weakened immune system due to the hiv virus, which allows for the growth of abnormal cells that can form tumors. this can lead to the development of multiple malignant neoplasms, which are tumors that can spread to other parts of the body.

What happens during the disease - hiv disease resulting in multiple malignant neoplasms

The pathogenesis of hiv disease resulting in multiple malignant neoplasms is complex and involves a combination of direct and indirect effects of the virus on the immune system. directly, hiv can infect and kill cd4+ t-cells, which are essential for the normal functioning of the immune system. indirectly, hiv can also disrupt the normal functioning of the immune system through chronic inflammation and oxidative stress, which can lead to an increased risk of developing multiple malignant neoplasms.

Clinical Pattern

More details coming soon

How does a doctor diagnose

Clinical examination of patient
Laboratory tests to measure HIV viral load
Imaging studies such as CT or MRI scans to detect any tumors
Biopsy of any suspicious lesions
Complete blood count (CBC) to assess for anemia
Tests to measure levels of other hormones and cytokines
Flow cytometry to detect abnormal cells
Tumor marker tests to detect any malignant cells

Treatment and Medical Assistance

Main goal of the treatment: To reduce the risk of malignant neoplasms associated with HIV disease

Provide antiretroviral therapy to reduce HIV viral load
Monitor HIV viral load levels regularly
Administer prophylactic antibiotics to reduce risk of opportunistic infections
Screen for malignant neoplasms on a regular basis
Provide chemotherapy, radiation therapy, or surgery to treat malignant neoplasms
Provide supportive care and symptom management
Ensure adherence to treatment regimens

28 Days of Hospitalization Required

Average Time for Outpatient Care Not Established

Hiv disease resulting in multiple malignant neoplasms - Prevention

To prevent hiv disease resulting in multiple malignant neoplasms, it is important to practice safe sex, use condoms, get tested regularly, and get vaccinated for hpv. additionally, it is important to practice good hygiene, get regular health screenings, and get vaccinated for other sexually transmitted infections.

Diseases with similar symptoms